pipecuronium bromide

DRUG2 trials

Sponsors

Tamas Vegh, MD

Conditions

Neuromuscular Blocking AgentsResidual Neuromuscular BlockReversal of Neuromuscular Blockade

Phase 4

Reversal of Pipecuronium-induced Neuromuscular Blockade With Sugammadex During Propofol Anesthesia

Active, not recruitingNCT07044180

Tamas Vegh, MDNeuromuscular Blocking Agents, Residual Neuromuscular Block, Reversal of Neuromuscular Blockade

Start: 2025-06-26End: 2028-12-31Target: 80Updated: 2025-08-07

Reversal of Pipecuronium-induced Neuromuscular Blockade With Sugammadex During Sevoflurane Anesthesia

Not yet recruitingNCT07044193

Tamas Vegh, MDNeuromuscular Blocking Agents, Residual Neuromuscular Block, Reversal of Neuromuscular Blockade

Start: 2025-06-26End: 2028-12-31Target: 80Updated: 2025-06-29